636 related articles for article (PubMed ID: 25879993)
1. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review.
Salahudeen MS; Duffull SB; Nishtala PS
BMC Geriatr; 2015 Mar; 15():31. PubMed ID: 25879993
[TBL] [Abstract][Full Text] [Related]
2. Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review.
Lisibach A; Benelli V; Ceppi MG; Waldner-Knogler K; Csajka C; Lutters M
Eur J Clin Pharmacol; 2021 Feb; 77(2):147-162. PubMed ID: 33011824
[TBL] [Abstract][Full Text] [Related]
3. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
Taylor-Rowan M; Kraia O; Kolliopoulou C; Noel-Storr AH; Alharthi AA; Cross AJ; Stewart C; Myint PK; McCleery J; Quinn TJ
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015196. PubMed ID: 35994403
[TBL] [Abstract][Full Text] [Related]
4. Anticholinergic Drug Burden Tools/Scales and Adverse Outcomes in Different Clinical Settings: A Systematic Review of Reviews.
Welsh TJ; van der Wardt V; Ojo G; Gordon AL; Gladman JRF
Drugs Aging; 2018 Jun; 35(6):523-538. PubMed ID: 29736815
[TBL] [Abstract][Full Text] [Related]
5. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes.
Hsu WH; Wen YW; Chen LK; Hsiao FY
Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497
[TBL] [Abstract][Full Text] [Related]
6. Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review.
Salahudeen MS; Duffull SB; Nishtala PS
Drugs Aging; 2014 Mar; 31(3):185-92. PubMed ID: 24526293
[TBL] [Abstract][Full Text] [Related]
7. Systematic review on the use of anticholinergic scales in poly pathological patients.
Villalba-Moreno AM; Alfaro-Lara ER; Pérez-Guerrero MC; Nieto-Martín MD; Santos-Ramos B
Arch Gerontol Geriatr; 2016; 62():1-8. PubMed ID: 26518612
[TBL] [Abstract][Full Text] [Related]
8. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
[TBL] [Abstract][Full Text] [Related]
9. Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties.
Hanlon P; Quinn TJ; Gallacher KI; Myint PK; Jani BD; Nicholl BI; Lowrie R; Soiza RL; Neal SR; Lee D; Mair FS
Ann Fam Med; 2020 Mar; 18(2):148-155. PubMed ID: 32152019
[TBL] [Abstract][Full Text] [Related]
10. A review of published anticholinergic scales and measures and their applicability in database analyses.
Lozano-Ortega G; Johnston KM; Cheung A; Wagg A; Campbell NL; Dmochowski RR; Ng DB
Arch Gerontol Geriatr; 2020; 87():103885. PubMed ID: 31155228
[TBL] [Abstract][Full Text] [Related]
11. Anticholinergic Burden Measures Predict Older People's Physical Function and Quality of Life: A Systematic Review.
Stewart C; Yrjana K; Kishor M; Soiza RL; Taylor-Rowan M; Quinn TJ; Loke YK; Myint PK
J Am Med Dir Assoc; 2021 Jan; 22(1):56-64. PubMed ID: 32709405
[TBL] [Abstract][Full Text] [Related]
12. Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models.
Al Rihani SB; Deodhar M; Darakjian LI; Dow P; Smith MK; Bikmetov R; Turgeon J; Michaud V
Drugs Aging; 2021 Nov; 38(11):977-994. PubMed ID: 34751922
[TBL] [Abstract][Full Text] [Related]
13. Anticholinergic burden measures and older people's falls risk: a systematic prognostic review.
Stewart C; Taylor-Rowan M; Soiza RL; Quinn TJ; Loke YK; Myint PK
Ther Adv Drug Saf; 2021; 12():20420986211016645. PubMed ID: 34104401
[TBL] [Abstract][Full Text] [Related]
14. An anticholinergic burden score for German prescribers: score development.
Kiesel EK; Hopf YM; Drey M
BMC Geriatr; 2018 Oct; 18(1):239. PubMed ID: 30305048
[TBL] [Abstract][Full Text] [Related]
15. Anticholinergic drug burden in older people's brain - how well is it measured?
Kersten H; Wyller TB
Basic Clin Pharmacol Toxicol; 2014 Feb; 114(2):151-9. PubMed ID: 24112192
[TBL] [Abstract][Full Text] [Related]
16. Anticholinergics: theoretical and clinical overview.
Nishtala PS; Salahudeen MS; Hilmer SN
Expert Opin Drug Saf; 2016 Jun; 15(6):753-68. PubMed ID: 26966981
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Anticholinergic Medication Burden and Health Related Outcomes in the 'Oldest Old': A Systematic Review of the Literature.
Cardwell K; Hughes CM; Ryan C
Drugs Aging; 2015 Oct; 32(10):835-48. PubMed ID: 26442862
[TBL] [Abstract][Full Text] [Related]
18. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
[TBL] [Abstract][Full Text] [Related]
19. Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people.
Salahudeen MS; Hilmer SN; Nishtala PS
J Am Geriatr Soc; 2015 Jan; 63(1):85-90. PubMed ID: 25597560
[TBL] [Abstract][Full Text] [Related]
20. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis.
Ruxton K; Woodman RJ; Mangoni AA
Br J Clin Pharmacol; 2015 Aug; 80(2):209-20. PubMed ID: 25735839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
